Skip to main content
. 2023 Feb 13;23(4):2112. doi: 10.3390/s23042112

Table 6.

Federated machine learning implementations in cancer prediction.

Ref Disease Data Used Performance
 [130] Brain tumor Brain MRI Segmentation Kaggle dataset [131] FL results outperform the baseline but classical ML models competed with their results
 [132] Brain tumor BraTS dataset [133] Dice = 0.86 for both FL and ML scenarios
 [134] Brain tumor BraTS dataset [133] FL performance is similar to ML models
 [135] Brain tumor Private data Dice=0.86 for both FL and ML scenarios
 [136] Skin cancer ISIC 2018 dataset [137] Accuracy = 91% for both FL and ML scenarios
 [138] Skin cancer ISIC 2019 Dermoscopy dataset [137] Accuracy: 89% which outperformed previous implementations
 [139] Breast cancer Private data from 7 different institutions FL perform 6.3% on average better than classical ML
 [140] Breast cancer Obtained from Netherlands Cancer Registry (NCR) Not available
 [141] Prostate cancer Private data FL model exhibited superior performance and generalizability to the ML models
 [142] Lung cancer Private data from 8 institutes across 5 countries Not available
 [143] Pancreatic cancer Data from hospitals in Japan and Taiwan FL models have higher generalizability than ML models
 [144] Thyroid cancer Private data from 6 institutions DL models outperformed FL models
 [145] Anal cancer Private data from 3 institutions Not available